Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

ClinicalTrials.gov ID: NCT02684006

Public ClinicalTrials.gov record NCT02684006. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 3:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, PARALLEL-ARM STUDY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AXITINIB (INLYTA(REGISTERED)) VERSUS SUNITINIB (SUTENT(REGISTERED)) MONOTHERAPY IN THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib monotherapy, administered as first-line treatment, in patients with advanced renal cell carcinoma

Study identification

NCT ID
NCT02684006
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
886 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2016
Primary completion
Aug 30, 2023
Completion
Jun 25, 2024
Last update posted
Jul 29, 2025

2016 – 2024

United States locations

U.S. sites
93
U.S. states
21
U.S. cities
44
Facility City State ZIP Site status
Southern Cancer Center Daphne Alabama 36526
Southern Cancer Center Mobile Alabama 36607
Southern Cancer Center Mobile Alabama 36608
Tower Hematology Oncology Medical Group Beverly Hills California 90211
City of Hope National Medical Center Duarte California 91010
City of Hope Duarte California 91010
Keck Hospital of USC Los Angeles California 90033
Los Angeles General Medical Center Los Angeles California 90033
USC IDS Pharmacy Los Angeles California 90033
USC/Norris Comprehensive Cancer Center Los Angeles California 90033
Cedars-Sinai Advanced Health Sciences Pavilion Los Angeles California 90048
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048
Cedars-Sinai Los Angeles California 90048
Rocky Mountain Cancer Centers Aurora Colorado 80012
University of Colorado Cancer Center Anschutz Cancer Pavilion Aurora Colorado 80045
University of Colorado Hospital - Clinical Trials Office (CTO) Aurora Colorado 80045
University of Colorado Hospital Aurora Colorado 80045
Rocky Mountain Cancer Centers Colorado Springs Colorado 80907
Georgetown University Medical Center Washington D.C. District of Columbia 20007
Moffitt Cancer Center and Research Institute Tampa Florida 33612
Emory University Hospital Atlanta Georgia 30322
Investigational Drug Service- Emory University Atlanta Georgia 30322
The Emory Clinic Atlanta Georgia 30322
Winship Cancer Institute, Emory University Atlanta Georgia 30322
East Jefferson General Hospital Metairie Louisiana 70006
East Jefferson Hematology-Oncology Metairie Physician Service Inc. Metairie Louisiana 70006
New England Cancer Specialists Kennebunk Maine 04043
New England Cancer Specialists Scarborough Maine 04074
New England Cancer Specialists Topsham Maine 04086
Oncology Investigational Drug Services- The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Baltimore Maryland 21231
Johns Hopkins Hospital Baltimore Maryland 21287
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21287
Massachusetts General Hospital (MGH) Boston Massachusetts 02114
Massachusetts General Hospital Clinical Trials Pharmacy Boston Massachusetts 02114
Brigham & Women's Hospital Boston Massachusetts 02115
Beth Israel Deaconess Medical Center (BIDMC) Boston Massachusetts 02215
Beth Israel Deaconess Medical Center Pharmacy - BIDMC Boston Massachusetts 02215
Dana - Farber Cancer Institute Boston Massachusetts 02215
Dana-Farber Cancer Institute Boston Massachusetts 02215
Baystate Franklin Medical Center Greenfield Massachusetts 01301
Mayo Clinic Rochester Minnesota 55905
Barnes-Jewish Hospital, Siteman Cancer Center - St. Peters City of Saint Peters Missouri 63376
Barnes-Jewish Hospital, Siteman Cancer Center - West County Creve Coeur Missouri 63141
Barnes-Jewish Hospital, Siteman Cancer Center St Louis Missouri 63110
Washington University Infusion Center Pharmacy St Louis Missouri 63110
Washington University School of Medicine St Louis Missouri 63110
Barnes-Jewish Hospital, Siteman Cancer Center - South County St Louis Missouri 63129
St. Vincent Healthcare Billings Montana 59101
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana Billings Montana 59102
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 75063
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
New York Oncology Hematology, P.C. Albany New York 12206
New York Oncology Hematology, PC Albany New York 12208
New York Oncology Hematology, P.C. Clifton Park New York 12065
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy Long Island City New York 11101
Laura & Isaac Perlmutter Cancer Center at NYU Langone New York New York 10016
NYU Investigational Pharmacy New York New York 10016
NYU Langone Medical Center New York New York 10016
MSKCC-Monitoring Suite New York New York 10017
Evelyn H. Lauder Breast and Imaging Center New York New York 10065
Memorial Sloan Kettering Cancer Center New York New York 10065
Sidney Kimmel Center for Prostate and Urologic Cancers New York New York 10065
Stony Brook University-Cancer Center Stony Brook New York 11794
Stony Brook University Stony Brook New York 11794
Novant Health Oncology Specialists Winston-Salem North Carolina 27103
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44106
Cleveland Clinic Cleveland Ohio 44195
James Cancer Hospital and Solove Research Institute Columbus Ohio 43210
The Ohio State University - GU Clinic Columbus Ohio 43210
The Ohio State University Columbus Ohio 43210
Cancer Care Associates Medical Oncology Allentown Pennsylvania 18104
St.Luke's Hospital-Allentown Campus Allentown Pennsylvania 18104
Cancer Care Associate Medical Oncology Bethlehem Pennsylvania 18015
St. Lukes University Health Network Bethlehem Pennsylvania 18015
St.Luke's Cancer Center Anderson Easton Pennsylvania 18045
St.Luke's Hospital-Anderson Campus Easton Pennsylvania 18045
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Investigational Drug Service, University of Pennsylvania Philadelphia Pennsylvania 19104
St.Luke's Quakertown Hospital Quakertown Pennsylvania 18951
Henry-Joyce Cancer Clinic Nashville Tennessee 37232
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246
Texas Oncology - Gulf Coast Houston Texas 77024
The University of Texas MD Anderson Cancer Center Houston Texas 77030
Investigational Product Center (IPC) Irving Texas 75063
Investigational Products Center (IPC) Irving Texas 75063
Investigational Products Center (lPC) Irving Texas 75063
US Oncology Investigational Products Center (IPC) Irving Texas 75063
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410
Rainier Hematology-Oncology, PC Puyallup Washington 98373
Fred Hutchinson Cancer Center Seattle Washington 98109
University of Washington Medical Center Seattle Washington 98195
Northwest Medical Specialties, PLLC Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 177 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02684006, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2025 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02684006 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →